Beta-Blocker Therapy in Severe TBI
link.springer.com
Propranolol decreases in-hospital mortality and improves long-term functional outcome in isolated severe Traumatic Brain Injury (TBI).
This randomized trial speaks in favor of routine administration of beta-blocker therapy as part of a standardized neurointensive care protocol.
219 randomized patients of whom 45% received BB were analyzed.
There were no significant demographic or clinical differences between BB+ and BB− cohorts.
No significant difference in in-hospital mortality or long-term functional outcome was measured between the cohorts.
Related Stories
Related Books
